loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Merimepodib

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Merimepodib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ViralClear Partners with AMRI on the Manufacture of Merimepodib API
    ViralClear Partners with AMRI on the Manufacture of Merimepodib API

    08 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2020/07/08/2059504/22558/en/ViralClear-Pharmaceuticals-partners-with-Albany-Molecular-Research-Inc-on-the-manufacture-of-merimepodib-active-pharmaceutical-ingredient-development-for-the-potential-treatment-of.html

    GLOBENEWSWIRE
    08 Jul 2020
    Share Share
    FDA Clears the invg NDA to Enable the PhII Trial of ViralClear’s Merimepodib
    FDA Clears the invg NDA to Enable the PhII Trial of ViralClear’s Merimepodib

    18 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/18/2034956/0/en/FDA-Clears-the-Investigational-New-Drug-Application-to-Enable-the-Phase-II-Trial-of-ViralClear-s-Merimepodib-Oral-Solution-to-Treat-Adult-Patients-with-Advanced-COVID-19-to-Proceed.html

    GLOBENEWSWIRE
    18 May 2020
    Share Share
    ViralClear Publishes in F1000 Research In Vitro Data Synergy between Merimepodib
    ViralClear Publishes in F1000 Research In Vitro Data Synergy between Merimepodib

    14 May 2020

    // PRESS RELEASE

    https://ir.biosig.com/press-releases/detail/199/viralclear-publishes-in-f1000-research-in-vitro-data

    PRESS RELEASE
    14 May 2020
    Share Share
    ViralClear Submits In Vitro Data Merimepodib and Remdesivir Synergistic Activity
    ViralClear Submits In Vitro Data Merimepodib and Remdesivir Synergistic Activity

    30 Apr 2020

    // BUSINESSINSIDER

    https://markets.businessinsider.com/news/stocks/viralclear-submits-in-vitro-data-on-merimepodib-and-remdesivir-synergistic-activity-against-the-covid-19-novel-coronavirus-to-a-peer-reviewed-journal-1029150595

    BUSINESSINSIDER
    30 Apr 2020
    Share Share
    ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir
    ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir

    23 Apr 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/04/23/2021020/0/en/ViralClear-Publishes-Comparative-In-Vitro-Data-on-Merimepodib-and-Remdesivir-Activity-Against-the-COVID-19-Novel-Coronavirus-in-F1000-Research.html

    GLOBENEWSWIRE
    23 Apr 2020
    Share Share